Radiance Medical Systems, Inc
This article was originally published in The Gray Sheet
Executive Summary
Investigational device exemption is filed with FDA for its RDX coronary radiation delivery system for prevention of restenosis (1"The Gray Sheet" March 8, p. 16). Human studies are expected to begin in the first quarter of 2000